113 related articles for article (PubMed ID: 20040644)
1. Induction of systemic lupus erythematosus with tumor necrosis factor blockers.
Soforo E; Baumgartner M; Francis L; Allam F; Phillips PE; Perl A
J Rheumatol; 2010 Jan; 37(1):204-5. PubMed ID: 20040644
[No Abstract] [Full Text] [Related]
2. Etanercept-associated SLE with lupus nephritis.
Neradová A; Stam F; van den Berg JG; Bax WA
Lupus; 2009 Jun; 18(7):667-8. PubMed ID: 19433471
[No Abstract] [Full Text] [Related]
3. [Drug-induced systemic lupus erythematosus: reports to The Netherlands Pharmacovigilance Centre Lareb].
van Rijthoven AW; van Roon JA
Ned Tijdschr Geneeskd; 2007 Apr; 151(14):839; author reply 839. PubMed ID: 17469329
[No Abstract] [Full Text] [Related]
4. Tumor necrosis factor-alpha antagonists induce lupus-like syndrome in patients with scleroderma overlap/mixed connective tissue disease.
Christopher-Stine L; Wigley F
J Rheumatol; 2003 Dec; 30(12):2725-7. PubMed ID: 14719225
[No Abstract] [Full Text] [Related]
5. Anti-TNF-alpha-induced systemic lupus syndrome.
Debandt M; Vittecoq O; Descamps V; Le Loët X; Meyer O
Clin Rheumatol; 2003 Feb; 22(1):56-61. PubMed ID: 12605321
[TBL] [Abstract][Full Text] [Related]
6. Infliximab-induced SLE-like syndrome involving the lung and pleura.
Diri E; Tello W; Ratnoff WD; Nugent K
Lupus; 2007; 16(9):764-6. PubMed ID: 17728373
[No Abstract] [Full Text] [Related]
7. Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey.
De Bandt M; Sibilia J; Le Loët X; Prouzeau S; Fautrel B; Marcelli C; Boucquillard E; Siame JL; Mariette X;
Arthritis Res Ther; 2005; 7(3):R545-51. PubMed ID: 15899041
[TBL] [Abstract][Full Text] [Related]
8. TNF inhibition in SLE: where do we stand?
Aringer M; Smolen JS
Lupus; 2009 Jan; 18(1):5-8. PubMed ID: 19074162
[No Abstract] [Full Text] [Related]
9. Role of anti-tumor necrosis factor-alpha blockers in inducing lupus erythematosus tumidus in "rhupus syndrome".
Chogle AR; Shah CV; Murthy AK
J Rheumatol; 2011 Jun; 38(6):1218-9. PubMed ID: 21632691
[No Abstract] [Full Text] [Related]
10. Anti-TNF-induced lupus.
Williams EL; Gadola S; Edwards CJ
Rheumatology (Oxford); 2009 Jul; 48(7):716-20. PubMed ID: 19416947
[TBL] [Abstract][Full Text] [Related]
11. Systemic lupus erythematosus in a patient treated with etanercept for polyarticular juvenile rheumatoid arthritis.
Bout-Tabaku S; Rivas-Chacon R; Restrepo R
J Rheumatol; 2007 Dec; 34(12):2503-4. PubMed ID: 18061971
[No Abstract] [Full Text] [Related]
12. Recent advances in rheumatology: biological agents for the treatment of rheumatoid arthritis, the progression of psoriatic arthritis, autoantibodies in systemic lupus erythematosus.
Finucane KA; Archer CB
Clin Exp Dermatol; 2005 Mar; 30(2):201-4. PubMed ID: 15725261
[No Abstract] [Full Text] [Related]
13. On anti-tumor necrosis factor-induced systemic lupus erythematosus.
Jacob N; Jacob CO
J Rheumatol; 2010 Jan; 37(1):3-5. PubMed ID: 20040635
[No Abstract] [Full Text] [Related]
14. Dermatological complications and safety of anti-TNF treatments.
Kerbleski JF; Gottlieb AB
Gut; 2009 Aug; 58(8):1033-9. PubMed ID: 19592682
[No Abstract] [Full Text] [Related]
15. Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study.
Aringer M; Graninger WB; Steiner G; Smolen JS
Arthritis Rheum; 2004 Oct; 50(10):3161-9. PubMed ID: 15476222
[TBL] [Abstract][Full Text] [Related]
16. Successful switch of patients with rheumatoid arthritis developing anti-tumor necrosis factor (anti-TNF)-induced lupus to another anti-TNF agent.
Ye C; Sholter D; Martin L; Keeling S
J Rheumatol; 2011 Jun; 38(6):1216; author reply 1217-8. PubMed ID: 21632690
[No Abstract] [Full Text] [Related]
17. Tumor necrosis factor blockers in rheumatoid arthritis.
Pisetsky DS
N Engl J Med; 2000 Mar; 342(11):810-1. PubMed ID: 10717018
[No Abstract] [Full Text] [Related]
18. High-titer Anti-aquaporin-4-IgG-associated Myelitis in Rhupus Syndrome.
Sciascia S; Roccatello D; Rossi D; Russo A; Mereuta MO; Cavallo R
J Rheumatol; 2012 Apr; 39(4):871-3. PubMed ID: 22467952
[No Abstract] [Full Text] [Related]
19. Successful treatment of refractory lupus-associated haemophagocytic lymphohistiocytosis with infliximab.
Ideguchi H; Ohno S; Takase K; Hattori H; Kirino Y; Takeno M; Ishigatsubo Y
Rheumatology (Oxford); 2007 Oct; 46(10):1621-2. PubMed ID: 17726035
[No Abstract] [Full Text] [Related]
20. Anti-TNF-alpha-induced lupus.
De Bandt M
Arthritis Res Ther; 2019 Nov; 21(1):235. PubMed ID: 31718696
[No Abstract] [Full Text] [Related]
[Next] [New Search]
